Showing results (111-120 of 384) with videos related to
Sort By:
Pageof 39
The Journal of Antimicrobial Chemotherapy|July 1, 1992
Concentrations of cefpodoxime in serum and bronchial mucosal biopsiesD R Baldwin, R Wise, J M Andrews, et al.The Journal of Antimicrobial Chemotherapy|April 1, 1990
The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporinsR Wise, J M Andrews, J P Ashby, et al.The Journal of Antimicrobial Chemotherapy|July 1, 1988
A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycinJ Kavi, J M Webberley, J M Andrews, et al.The Journal of Antimicrobial Chemotherapy|December 1, 1991
Comparative pharmacokinetic disposition of fluoroquinolones in the lungR Wise, D R Baldwin, J M Andrews, et al.FEMS Microbiology Letters|June 15, 1994
Determination of OPC-17116, a new fluoroquinolone, in human alveolar macrophages and other biological matrices by high performance liquid chromatography (HPLC)J M Woodcock, J M Andrews, D Honeybourne, et al.The Journal of Antimicrobial Chemotherapy|August 1, 1988
The penetration of fleroxacin into bronchial mucosaR Wise, D Honeybourne, J M Andrews, et al.The Journal of Antimicrobial Chemotherapy|June 26, 1999
Bactericidal properties of moxifloxacin and post-antibiotic effectF J Boswell, J M Andrews, R Wise, et al.Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi|July 1, 1996
[The postantibiotic effect of azithromycin on respiratory pathogens]D Diculencu, J M Andrews, F J Boswell, et al.The Journal of Antimicrobial Chemotherapy|October 3, 2002
Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistanceF J Boswell, J M Andrews, G Jevons, et al.The Journal of Antimicrobial Chemotherapy|April 1, 1985
The antimicrobial activity of cefpirome, a new cephalosporinR Wise, J M Andrews, C Cross, et al.Pageof 39